IRVINE, Calif.–(BUSINESS WIRE)–Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers each individual by offering entry to correct, scientific testing, introduced right this moment a brand new partnership with AIMA Laboratories (AIMA), a preclinical FemTech firm devoted to creating new merchandise that fill present gaps in gynecological well being, to develop and ship a brand new and dependable at-home blood take a look at to detect endometriosis.
Endometriosis is a illness the place tissue much like the liner of the uterus grows exterior the uterus, inflicting ache and/or infertility. For the roughly 10% of reproductive age girls and ladies globally who’ve endometriosis – roughly 190 million – there’s a important hole between when signs first seem and when they’re identified, which might sometimes take round 5 to 12 years.
“We’re thrilled to accomplice with AIMA to supply a service that gives actionable outcomes and permits tens of millions of girls entry to early diagnostic instruments to detect endometriosis, carving a path to the best care, on the proper time and when it’s most handy,” stated David White, IHD CEO and Co-Founder. “At IHD, it’s our mission to ship options that present hope to folks fighting infertility, and our partnership with AIMA additional permits that mission.”
The take a look at identifies sure microRNA biomarkers which are differentially expressed in girls with endometriosis in comparison with girls with out. The take a look at’s accuracy is similar to laparoscopy, a kind of surgical procedure that’s used to get a better look into a lady’s stomach and reproductive system. Laparoscopy is used to each diagnose and deal with endometriosis, detecting and eradicating endometrial lesions. As a result of laparoscopy is a extra invasive process, it usually takes years for ladies to get examined and handled.
The brand new IHD-AIMA take a look at will complement laparoscopic procedures. The take a look at will each assist remove diagnostic delays, enabling a noninvasive method to take a look at for endometriosis, and permit for sufferers who obtain a optimistic take a look at outcome to bear a laparoscopy for therapy doubtlessly years earlier than they might in any other case.
“At AIMA, our mission is to shorten a lady’s path to a more healthy tomorrow,” defined Dr. Lauren Foster, Ph.D., Co-Founder and CEO of AIMA. “We’re working to construct a world the place girls actively take part in their very own healthcare selections, beginning with endometriosis diagnostics. Our partnership with IHD permits us to serve the tens of millions impacted by this debilitating situation and provides them with an answer to diagnostic delays.”
About Revolutionary Well being Diagnostics
Revolutionary Well being Diagnostics (IHD) empowers each individual by offering entry to correct, scientific testing, when and the place it issues most. IHD companies embody fertility and in vitro fertilization (IVF) testing; FDA donor testing for households finishing surrogacies; and COVID-19 polymerase chain response (PCR) and antibody testing.
A nimble, collaborative accomplice, IHD operates with the affected person in thoughts always, providing the best requirements of integrity and repair, fast turnaround occasions, and affordability. To be taught extra, please go to ihdlab.com or observe us on LinkedIn, Twitter, Facebook and Instagram.
About AIMA Laboratories
AIMA Laboratories Inc. is a Canadian, pre-clinical FemTech firm co-founded by two scientists who’ve devoted their skilled lives to researching reproductive endocrinology and infertility. Our objective is to develop new merchandise to fill present gaps in gynecological well being.